2m 2m 2m 2m 2m 2m 2m
Vaxxinity-A (VAXX)
OTC
$0.06+$0.06 (+28,650.00%)
Price as of May 13, 2024 10:06 AM EDT- $13.9MMarket Cap
- 100.00%1-Year Change
- BiotechnologyIndustry
Vaxxinity-A (VAXX)
$0.06+$0.06 (+28,650.00%)
VAXX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | +$0.0001 (+100.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 351 | ||
30-Day Average Volume | 5,496 | ||
1-Week Change | 100.00% | ||
1-Month Change | 19,900.00% | ||
1-Year Change | 100.00% | ||
3-Year Change | -99.99% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 126.7M | ||
Total Assets | $44.3M | ||
Market Cap | $13.9M | ||
Enterprise Value | $29.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$11.4M | ||
Free Cash Flow | -$12.3M | ||
EBIT | -$11.2M | ||
EBITDA | -$10.8M | ||
Net Working Capital | $15.6M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||